-transparent.png){kind=logo}
The association of exposure to bleomycin with the development of scleroderma-like cutaneous abnormalities has been reported. We experienced a case of scleroderma involving the hands, feet, and forearms after bleomycin chemotherapy. The present report supports the possible causal relation of bleomycin with scleroderma. Regarding the widespread use of bleomycin, this complication is thought to be under appreciated.
Related Publications
K H Kim, and
T J Yoon, and
C W Oh, and
G H Ko, and
T H Kim
May 2012,
The Journal of dermatology,
K H Kim, and
T J Yoon, and
C W Oh, and
G H Ko, and
T H Kim
January 1980,
The Journal of rheumatology,
K H Kim, and
T J Yoon, and
C W Oh, and
G H Ko, and
T H Kim
January 2004,
The Journal of the Association of Physicians of India,
K H Kim, and
T J Yoon, and
C W Oh, and
G H Ko, and
T H Kim
January 2011,
International journal of rheumatology,
K H Kim, and
T J Yoon, and
C W Oh, and
G H Ko, and
T H Kim
February 2008,
Rheumatology (Oxford, England),
K H Kim, and
T J Yoon, and
C W Oh, and
G H Ko, and
T H Kim
February 2013,
Inflammation,
K H Kim, and
T J Yoon, and
C W Oh, and
G H Ko, and
T H Kim
August 2018,
Turkish journal of medical sciences,
K H Kim, and
T J Yoon, and
C W Oh, and
G H Ko, and
T H Kim
February 2006,
Archives of dermatological research,
K H Kim, and
T J Yoon, and
C W Oh, and
G H Ko, and
T H Kim
January 2013,
Veterinary pathology,
K H Kim, and
T J Yoon, and
C W Oh, and
G H Ko, and
T H Kim
September 2015,
European journal of rheumatology,
